- Sznajder, L.J., et al. 2023. Autistic traits in myotonic dystrophy type 1 due to MBNL inhibition and RNA mis-splicing. Nat. Neurosci., PMID:37645891. PMCID: PMC10462192.
- Recinos, Y., et al. 2024. Lineage-specific splicing regulation of MAPT gene in the primate brain. Cell Genom. 4:100563. PMID:38772368. PMCID: PMC11228892.
- Bubenik, J.L., et al. 2024. Therapeutic targeting of RNA for neurological and neuromuscular disease. Genes Dev. 38:698-717. PMID:39142832. PMCID: PMC11444190.
- Davenport, M.L., et al. 2024. Spiny mice are primed but fail to regenerate volumetric skeletal muscle loss injuries. Skelet. Muscle 14:26. doi: 10.1186/s13395-024-00358-y. PMID:39468576. PMCID: PMC11520498.
- Mirceta, M., et al. 2024. C9orf72 repeat expansion creates the unstable folate-sensitive fragile site FRA9A. NAR Mol. Med., doi: 10.1093/narmme/ugae019. PMID:39669124. PMCID: PMC11632612.
- Kidd, B.M., et al. 2024. Stroke-induced neuroplasticity in spiny mice in the absence of tissue regeneration. NPJ Regen. Med., doi.org/10.1038/s41536-024-00386-8. PMID: 39706830. PMCID: PMC11662029.
- Davenport, M.L., and M.S. Swanson. 2024. RNA gain-of-function mechanisms in short tandem repeat diseases. RNA, doi: 10.1261/rna.080277.124. PMID:39725460. PMCID: 11874975.
- Sznajder, L.J., et al. 2025. Autism-related traits in myotonic dystrophy type 1 model mice are due to MBNL sequestration and RNA mis-splicing of autism-risk genes. Nat. Neurosci. 28:119-1212, PMID:40259070.
- Fukumoto,A., et al. 2025. Transcriptome alterations underlying metabolic dysfunction and liver disease in myotonic dystrophy type 1. Hum Mol.Genet., online ahead of print. PMID: 40801161
- Davenport, M.L, et al. 2025. Differential pathology and susceptibility to MBNL loss across muscles in myotonic dystrophy mouse models. JCI Insight. PMID:40811031. PMCID: PMC12487862.